Modeling Melanoma In Vitro and In Vivo
暂无分享,去创建一个
Nikolas K. Haass | N. Haass | K. A. Beaumont | Kimberley A. Beaumont | Nethia Mohana-Kumaran | Nethia Mohana-Kumaran
[1] A. Trumpp,et al. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. , 2005, Cancer research.
[2] Kam Y. J. Zhang,et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.
[3] K. Flaherty,et al. Meeting report: The future of preclinical mouse models in melanoma treatment is now , 2013, Pigment cell & melanoma research.
[4] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[5] S. Morrison,et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.
[6] L. Zon,et al. The art and design of genetic screens: zebrafish , 2001, Nature Reviews Genetics.
[7] T. Terzian,et al. Modelling melanoma in mice , 2011, Pigment cell & melanoma research.
[8] Yu Shyr,et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. , 2012, The New England journal of medicine.
[9] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[10] R. Ley. Animal models of ultraviolet radiation (UVR)-induced cutaneous melanoma. , 2002, Frontiers in bioscience : a journal and virtual library.
[11] M. Herlyn,et al. The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel , 2008, Clinical Cancer Research.
[12] L. Larue,et al. Cutaneous melanoma in genetically modified animals. , 2007, Pigment cell research.
[13] K. Flaherty,et al. Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.
[14] N Cascinelli,et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] N. Haass,et al. Cell-cell and cell-matrix contacts in melanoma and the tumor microenvironment , 2011 .
[16] Kam Y. J. Zhang,et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma , 2010, Nature.
[17] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[18] R. Scolyer,et al. Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma , 2005, Journal of Clinical Pathology.
[19] M. Herlyn,et al. Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.
[20] G. Nicolson,et al. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. , 1976, Journal of the National Cancer Institute.
[21] M. Grabherr,et al. A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse , 2008, Nature Genetics.
[22] S. Beissert,et al. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing , 2013, Cell Death and Disease.
[23] D. Elder,et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. , 2000, The American journal of pathology.
[24] M. Herlyn,et al. Fibroblasts contribute to melanoma tumor growth and drug resistance. , 2011, Molecular pharmaceutics.
[25] M. Herlyn,et al. PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas , 2010, Pigment cell & melanoma research.
[26] M. Herlyn,et al. Melanocytes: From Morphology to Application , 2009, Skin Pharmacology and Physiology.
[27] Wolfgang Weninger,et al. A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. , 2013, Cancer research.
[28] Kevin W. Eliceiri,et al. Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage , 2009, Oncogene.
[29] Christine Unger,et al. In vitro cell migration and invasion assays. , 2013, Mutation research.
[30] D. Elder,et al. A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.
[31] J. Castle,et al. Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.
[32] K. Hunter,et al. Modeling metastasis in vivo. , 2004, Carcinogenesis.
[33] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[34] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[35] R. DePinho,et al. BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.
[36] Mark Shackleton,et al. Efficient tumour formation by single human melanoma cells , 2008 .
[37] I. Gimenez-Conti,et al. Genetic Analysis of Neoplasia Induced by N-Nitroso-N-methylurea in Xiphophorus Hybrid Fish , 2001, Marine Biotechnology.
[38] N. Haass,et al. Melanoma's connections to the tumour microenvironment. , 2013, Pathology.
[39] Z. Werb,et al. Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.
[40] Z. Abdel‐Malek,et al. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. , 2011, Molecular endocrinology.
[41] F. Bérard,et al. The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): clinical-pathological characterization. , 2000, Pigment cell research.
[42] M. Herlyn,et al. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1 , 2006, The Journal of cell biology.
[43] C. Busch,et al. Noggin blocks invasive growth of murine B16‐F1 melanoma cells in the optic cup of the chick embryo , 2008, International journal of cancer.
[44] C. Busch,et al. The Chick Embryo as an Experimental System for Melanoma Cell Invasion , 2013, PloS one.
[45] Eric Brown,et al. Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. , 2005, The American journal of pathology.
[46] Morag Park,et al. Dynamics of receptor trafficking in tumorigenicity. , 2012, Trends in cell biology.
[47] M. Herlyn,et al. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway , 2011, Oncogene.
[48] R. DePinho,et al. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. , 2002, Cancer research.
[49] C. Busch,et al. Neural crest cell migration of mouse B16-F1 melanoma cells transplanted into the chick embryo is inhibited by the BMP-antagonist noggin. , 2007, International journal of oncology.
[50] C. Busch,et al. Non-malignant migration of B16 mouse melanoma cells in the neural crest and invasive growth in the eye cup of the chick embryo , 2007, Melanoma research.
[51] D. Rimm,et al. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. , 2011, Cancer cell.
[52] W. Silvers,et al. Transgenic mouse model of malignant skin melanoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[53] C. Busch,et al. Human SK-Mel 28 melanoma cells resume neural crest cell migration after transplantation into the chick embryo , 2005, Melanoma research.
[54] M. Schartl,et al. A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies. , 2010, The Journal of investigative dermatology.
[55] Mohamed H. Sayegh,et al. Identification of cells initiating human melanomas , 2008, Nature.
[56] Baocun Sun,et al. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines , 2013, Melanoma research.
[57] M. Herlyn,et al. In vitro three-dimensional tumor microenvironment models for anticancer drug discovery , 2008, Expert opinion on drug discovery.
[58] Shelly R. Peyton,et al. A novel three-dimensional model to quantify metastatic melanoma invasion , 2007, Molecular Cancer Therapeutics.
[59] J. Spitsbergen. Imaging neoplasia in zebrafish , 2007, Nature Methods.
[60] S. Holmen,et al. Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma , 2011, Chinese journal of cancer.
[61] M. Herlyn,et al. Fibroblast‐dependent differentiation of human microvascular endothelial cells into capillary‐like, three‐dimensional networks , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[62] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[63] D. Elder,et al. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. , 1993, The American journal of pathology.
[64] L. Chin,et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.
[65] Keith T Flaherty,et al. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases , 2006, Molecular Cancer Therapeutics.
[66] C. Garbe,et al. Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment , 2007, The British journal of dermatology.
[67] D. Iliopoulos,et al. In vitro properties of human melanoma cells metastatic in nude mice. , 1990, Cancer research.
[68] D. Mitchell,et al. Genetic and environmental melanoma models in fish , 2010, Pigment cell & melanoma research.
[69] A. P. Butler,et al. Genetic Analysis of Susceptibility to Spontaneous and UV-Induced Carcinogenesis in Xiphophorus Hybrid Fish , 2001, Marine Biotechnology.
[70] Wolfgang Link,et al. Protein localization in disease and therapy , 2011, Journal of Cell Science.
[71] R. Walter,et al. Xiphophorus interspecies hybrids as genetic models of induced neoplasia. , 2001, ILAR journal.
[72] C. Busch,et al. Melanoma cells in distinct growth phases retain specific invasive qualities during brain metastasis in vivo , 2012, Pigment cell & melanoma research.
[73] L. Chin,et al. Animal models of melanoma: recent advances and future prospects. , 2000, Advances in cancer research.
[74] R R Hook,et al. Melanoma in Sinclair swine: a new animal model. , 1974, The Journal of investigative dermatology.
[75] P. Hersey,et al. The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance. , 2013, Carcinogenesis.
[76] J. Reis-Filho,et al. Oncogenic Braf induces melanocyte senescence and melanoma in mice. , 2009, Cancer cell.
[77] A. Jemal,et al. Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.
[78] F. Bérard,et al. The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): epidemiological survey. , 2000, Pigment cell research.
[79] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[80] P. Hersey,et al. Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737 , 2011, Clinical Cancer Research.
[81] Leonard I. Zon,et al. Cancer genetics and drug discovery in the zebrafish , 2003, Nature Reviews Cancer.
[82] M. Amoss,et al. Regression by differentiation in the Sinclair swine model of cutaneous melanoma , 1997, Melanoma research.
[83] D. Elder,et al. Human melanoma progression in skin reconstructs : biological significance of bFGF. , 2000, The American journal of pathology.
[84] C. Berking,et al. Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology. , 2001, Histology and histopathology.
[85] L. Zon,et al. BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma , 2005, Current Biology.